ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Smokeless Tobacco Consensus Conference Slates in Health Risks

August 16, 1985

Varmus: NCI Faces “Budgetary Disaster;” Flat Funds, Cuts Loom For Most Programs

January 14, 2011

Clearinghouse Says In Business

January 26, 1979

NCI, Groups Disagree Over repayment, McIntyre: NCA Could Examine Relationship of Groups To NCI

December 9, 1994

Research Opportunities On Diet, Nutrition Outlined To NCAB

July 11, 1975